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The epidemiological transition in sub-Saharan Africa (SSA) has given rise to a con-
comitant increase in the incidence of non-communicable diseases including cancers.
Worldwide, cancer registries have been shown to be critical for the determination of
cancer burden, conduct of research, and in the planning and implementation of cancer
control measures. Cancer registration though vital is often neglected in SSA owing
to competing demands for resources for healthcare. We report the implementation of
a system for representative nation-wide cancer registration in Nigeria – the Nigerian
National System of Cancer Registries (NSCR). The NSCR coordinates the activities
of cancer registries in Nigeria, strengthens existing registries, establishes new reg-
istries, complies and analyses data, and makes these freely available to researchers
and policy makers. We highlight the key challenges encountered in implementing
this strategy and how they were overcome. This report serves as a guide for other
low- and middle-income countries (LMIC) wishing to expand cancer registration cov-
erage in their countries and highlights the training, mentoring, scientific and logistic
support, and advocacy that are crucial to sustaining cancer registration programs
in LMIC.
Keywords: cancer registration, Nigeria, population-based cancer registries, cancer incidence, cancer
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Introduction
Sub-Saharan African (SSA) countries are now undergoing an
epidemiological transition with increasing incidence of non-
communicable diseases (NCD) occurring alongside persistence of
communicable diseases epidemic (1, 2). These two epidemics are
also feeding off each other with infections like HIV, Hepatitis B
andC,Helicobacter pylori leading to increased incidence of certain
cancers and rising prevalence of other risk factors for cancer
(3–5). In addition, increased life expectancy, reduced mortality
from infectious diseases, increasing urbanization, and western-
ization leading to changes in lifestyle, dietary, obstetrics, and
physical activity practices in this region have been associated with
increased risk of NCD including cancer (3, 6, 7). The HIV/AIDS
epidemic and prevalent oncogenic infections are also contributing
significantly to SSA’s rising cancer burden (8, 9).
With this has come the realization that information from cancer
registries is vital for monitoring the incidence, prevalence and
mortality of cancer, the effectiveness of national cancer prevention
and cancer control initiatives, resource allocation, and public
policy related to cancer control (10). Although recent literature
report an increase in cancer incidence in developing countries,
poor vital and cancer registration remains a widespread problem
such that reliable information on cancer incidence and mortality
is scarce (5, 11–13). Cancer registries are veritable tools for col-
lecting accurate and complete information on cancer incidence,
prevalence, and mortality in a given geographical location and
they can be used to conduct research, plan and implement cancer
control, allocate resources for treatment and prevention, and other
public health program planning (14). Cancer registries serve as
a starting point for basic research and etiological studies and
therefore play a crucial role in cancer prevention. Where cancer
registries collect information on follow-up, they can be used to
assess the survival of cancer patients and evaluate the efforts made
at improving survival.
Despite these acknowledged utilities of cancer registration, can-
cer registries are not yet an integral part of cancer control in most
low- andmiddle-income countries (LMIC). In those LMIC where
resources exist and cancer control policies have been formulated,
there is often a lack of political will to rigorously implement these
policies (15). The implication is that policy makers in LMIC lack
information about the population burden of cancer and its health,
economic, and political implications (10, 13).
In this paper, we report the history of cancer registration in
Nigeria and, the conceptualization as well as recent implementa-
tion of a system for representative nation-wide cancer registration
in Nigeria. We highlight the key challenges encountered in imple-
menting this strategy and how they were overcome. This report
may provide guidance for other LMIC as they implement cancer
registration programs.
History of Cancer Registration in the World
and Africa
The registration of cancer cases began with several unsuccess-
ful attempts at cancer surveys in the United Kingdom in 1728,
Germany in 1900, and Netherlands and Spain in 1902 and 1908
(16). After several sporadic attempts at population-based cancer
registration in Germany in 1926, USA, Denmark, England, and
Canada in 1940s (17), the need for the establishment of cancer
registries throughout the world was recommended to the World
Health Organization (WHO) by leading experts in the field of
cancer control (17). A few years later, the WHO established
a subcommittee mandated to proffer recommendations for the
establishment of cancer registries.
The specialized arm of the WHO that deals with cancer, the
International Agency for Research on Cancer (IARC) was formed
in 1965 and the following year, the International Association of
Cancer Registries (IACR) was founded (16). The IACR and IARC
through their activities have promoted the development of cancer
registration in many developing regions including SSA. Cancer
registration in Africa began in 1950s with registries in South
Africa, Uganda, Nigeria, and Zimbabwe (Table 1).
These African registries contributed cancer incidence data
to the WHO/IARC Cancer in five Continents (CIV) publica-
tions; [Mozambique: Lorenco Marques; Nigeria: Ibadan; South
Africa: Johannesburg, Bantu and Uganda: Kyadondu (Volume 1),
SouthAfrica: CapeProvince; SouthAfrica: Johannesburg;Nigeria:
Ibadan; Zimbabwe Bulawayo (Volume 2), Nigeria: Ibadan; and
Zimbabwe: Bulawayo (Volume 3)] until the late 1970s and 1980s
when an economic recession and accompanying “brain drain”
spread throughout Africa. Since then other registries that have
contributed to subsequent CIV volumes include registries Dakar
Senegal, Mali, The Gambia, and Harare Zimbabwe.
Although many African registries submit data for the CIV
publication, data quality issues usually result in a good number
of submissions being screened out. However, over the last decade,
there has been a gradual reawakening of the need for cancer reg-
istries that can generate high-quality data with a resultant increase
in the number of IARC acknowledged PBCRs (member registries
of the African Cancer Registry Network) in Africa (Table 2) (18).
Cancer Registration in Nigeria
Nigeria is the most populous country in Africa.With a population
of approximately 168 million people, it represents over 50% of the
population of the West African sub-region and slightly <20% of
the population of Africa (19). The country was recently reclassi-
fied by The World Bank as a lower middle income country with a
total GDP of $568.5 billion, GDP per capita of $2,688 and a total
health expenditure of 5.3% (19). Life expectancy in the country
also increased from 47 years in 2001 to 52 years in 2011 (19).
Improvement in cancer registration in Nigeria is therefore likely
TABLE 1 | Earliest cancer registries in sub-Saharan Africa (45).
Registry/country Year registry
was founded
Founder
Johannesburg, South Africa (SA) 1953 Higginson and Oettle
Kampala, Uganda 1954 Davis, Templeton
Cape Town, South Africa 1956 Muir Grieve
Lorenco Marques, Mozambique 1956 Prates
Ibadan, Nigeria 1960 Edington
Bulawayo, Zimbabwe 1963 Skinner
Durban, South Africa 1964 Schonland and Bradshaw
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TABLE 2 | Population-based cancer registries in sub-Saharan Africa in 2013 (Source: www.afcrn.org) (18).
Country
(Number of PBCRs)
Registries Country Population
(m=million) (t = thousand)
Population covered
by registry
Year of
conception
Botswanaa (1) Botswana National Cancer Registry 2,024,787 m 2,024,787 m 1999
Brazzavillea (1) Registre des Cancers de Brazzaville 4,337,051 m 4,337,051 m 1995
Cote d’Ivoire (1) Registre des Cancers d’Abidjan 19,839,750 m 3,772,230 m 1994
Ethiopia (1) Addis Ababa Cancer Registry 91,728,849 m 3,384,569 m 2011
The Gambiaa (1) Gambia National Cancer Registry 1,791,225 m 1,791,225 m 1986
Ghana (1) Kumasi Cancer Registry 25,366,462 m 2,035,064 m 2012
Guinea (1) Registre de Cancer de Guinea 11,451,273 m 1,656,300 m 1990
Kenya (2) Eldoret Cancer Registry 43,178,141 m 894,179 t 1999
Nairobi Cancer Registry 3,138,369 m 2001
Malawi (1) Malawi Cancer Registry 15,906,483 m 1,895,973 m 1993
Mauritiusa (1) Mauritius Cancer Registry 1,291,456 m 1,291,456 m 1993
Mozambique (1) Registre de Cancro de Beira 25,203,395 m 457,799 t 2005
Namibiaa (1) Namibia Cancer Registry 2,259,393 m 2,259,393 m 1995
Niger (1) Registre des Cancers du Niger 17,157,042 m 1,011,227 m 1992
Nigeria (3) Abuja Cancer Registry 168,833,776 m 1,406,239 m 2009
Calabar Cancer Registry 647,458 t 2004
Ibadan Cancer Registry 2,549,265 m 1960
Rwanda (1) Rwanda Cancer Registry 11,457,801 m – 1991
Seychellesa (1) Seychelles National Cancer Registry 88,303 t 88,303 t 2008
South Africa (3) South African Children’s Cancer Group (SACCSG) Tumor 52,274,945 m 15,800,000 m 1987
Registry South African National Cancer Registry (Pathology-based) 52,274,945 m 1986
PROMEC Cancer Registry, Eastern Cape 1,300,000 m
Tanzania (1) Tanzania Cancer Registry 47,783,107 m 4,364,541 m 2009
Uganda (1) Kampala Cancer Registry 36,345,860 m 2,010,000 m 1951
Zimbabwe (1) Zimbabwe National Cancer Registry 13,724,317 m 1,468,766 m 1985
aRegistries with national coverage.
to contribute significantly to the proportion of Africans covered
by this method of cancer surveillance.
In Nigeria, cancer registration began in 1960 with the first
cancer registry located within the Pathology Department of the
University College Hospital Ibadan, in South Western Nigeria.
Cancer incidence data from this registry were included in the
first three volumes of Cancer Incidence in five continents (CIV)
for the time periods 1960–1962, 1960–1965, and 1960–1969 (20).
Edington and Mclean published the first paper on the cancer
profile in Nigeria with data from the Ibadan cancer registry in the
British Journal of Cancer in 1965 (21). All through this period,
the Ibadan Cancer Registry was the only population-based cancer
registry in Nigeria contributing data to CIV.
However, between the seventies and end of 2000s, the Ibadan
Cancer Registry stopped submitting data to CIV. The reasons
for this include severe economic, political, and social upheavals
that affected Nigeria during this period. The severe economic
retrogression led to high levels of emigration by educated citi-
zens including doctors, many of whom had trained abroad and
returned to the countries where they trained or to theMiddle East
(22). This brain drain, along with marked reduction in funding
to public health care systems, led to the demise of many cancer
registries, stymied the development of new ones and retarded
efforts at integrating the cancer registries into a national cancer
data reporting system.
During the four decades interregnum when there was no reli-
able information on cancer incidence, prevalence, and mortality
in the country, most published cancer data were based on case
series, medical and pathology departments’ records, and mor-
tality reports from autopsies (23). These are not valid sources
of cancer incidence data because they do not provide informa-
tion on cancer incidence in the general population (24). Most
of these data sources were limited in scope and coverage often
leading to overrepresentation of easy to biopsy tumors and may
bemore reflective of the nature of clinical practice, personnel, and
infrastructure in the reporting institutions (25). There was also
declining practice of autopsy in Nigeria throughout this period
(26). Over-interpretation and misunderstanding of the data from
these sources has led to significantmisunderstanding of the cancer
incidence in Nigeria and similar LMIC to date.
The first attempt to coordinate the activities, provide training
and mentoring, as well as ensure a uniform standard of reporting
for all cancer registries in Nigeria led to the establishment of the
National Headquarters of Cancer Registries in Nigeria (NHCRN)
by theNigerian FederalMinistry of Health (FMOH) in 1990s. The
NHCRN led by an Executive Chairman, Professor of Surgery Tori-
ola Feyisetan Solanke at the University College Hospital (UCH)
and the College of Medicine, University of Ibadan, Ibadan, Nige-
ria, was initially located at the Department of Surgery and later in
the Department of Radiotherapy, UCH, Ibadan, Nigeria.
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The NHCRN implemented training programs, conducted pub-
lic advocacy and supplied resource materials to several cancer
registries in the country. Data fromdifferent cancer registries were
collated and some of this was published in 1998 (27). For several
years, the data published by NHCRN were the reference infor-
mation on cancer incidence data in Nigeria. However, the death
of the pioneer Executive Chairman of the NHCRN, continuing
economic difficulties and failures in the public health systems in
Nigeria conspired to make the NHCRN largely non-functional
from 2002. During this period and afterwards, IARC continued to
support the Ibadan, Ile-Ife and Calabar registries and other cancer
registration activities in Nigeria even as the quality of the data
produced often fell short of the standard required for publication
in CIV.
Implementing a National System of Cancer
Registration in Nigeria
Although cancer registration began decades ago in Nigeria,
progress over the past 50 years has been slow, patchy, and halt-
ing. Previous efforts at achieving quality population-based cancer
registries have not been sustained. This poor progression to highly
functional population-based cancer registration has been mainly
as a result of lack of financial and institutional support for cancer
registries, ignorance of the need for cancer registration and poorly
trained staff and registry personnel. With the advent of demo-
cratic rule in Nigeria, improvements in public health financing
and management, there has been a renewal of interest in cancer
registration.
In 2009, the Nigerian FMOH, Society of Oncology and Cancer
Research ofNigeria (SOCRON–http://socron.net/) and the Insti-
tute of HumanVirology Nigeria (IHVN) conceptualized the Nige-
rianNational System of Cancer Registries (NSCR) as amethod for
generating cancer incidence data that covers different sections of
the country with support from the Fogarty International Center
and the National Cancer Institute of the United States’ National
Institutes of Health and the Marlene and Stewart Greenebaum
Cancer Center, University of Maryland School of Medicine. The
main objective of the NSCR is to provide training, capacity devel-
opment, mentoring, technical, and scientific support to cancer
registries in Nigeria to enable them attain population-based can-
cer registration status and generate high-quality cancer incidence,
treatment, and survival data for the country.
The NSCR coordinates the activities of the cancer registries
and generates aggregate national cancer incidence, treatment,
and survival data; disseminate the data to relevant government
agencies for use in policy formulation and resource allocation;
to scientists conducting cancer research; and to the public for
education, awareness, and advocacy purposes. The NSCR also
advocates for cancer registration in the country, increase aware-
ness of cancer, advocate and publish locally relevant cancer data.
In order to achieve these objectives, NSCR works to strengthen
existing cancer registries, establish new registries through the
provision of training, mentoring, computer hardware and soft-
ware, and provide support for data management and analysis. The
NSCR has brought more visibility to the growth and expansion
of cancer registries in Nigeria. Through the establishment of the
NSCR, there is amore cohesive and synergized approach to cancer
registration in the country. In the past, sporadic attempts by many
individual cancer registries had been made that did not yield
tangible gains.With collation of data from various registries across
different geo-political zones, we are able to show variations in
cancer incidence, which are helpful in tailoring cancer prevention
and control programs.
Through this collaboration, Nigerian cancer registry data are
now more easily accessible to researchers with the consent of the
individual cancer registries. TheNSCR also helps prevent data loss
at cancer registry sites. In instanceswhere data loss is encountered;
the data have easily been retrieved from the NSCR database.
Through the NSCR, linkages are made with other databases to
enable Nigerian registry data reach a wider and more relevant
audience.
Activities of the Nigerian National System
of Cancer Registries
Training
In its first few years, NSCR focused on providing training and
building the capacity of existing cancer registries with the aim of
improving the quality of data generated by these registries. These
trainings were provided in collaboration with several interna-
tional partners including the IARC and International Prevention
Research Institute (iPRI) and funded by theUnited StatesNational
Institutes of Health, GreenebaumCancer Center of the University
of Maryland School of Medicine, Baltimore and the Nigerian
FMOH (Figure 1).
National System of Cancer Registries has trained and re-trained
over 70 registry directors, cancer registrars, and data clerks to
date. Training programs have focused on principles of cancer
registration, basic cancer epidemiology, the use of CanReg – the
cancer registration software developed by IARC (Initially version
4 and later version 5), coding and classification schemes, data
quality control, cancer staging and grading, data presentation,
management and analysis, and preparation of reports.
Mentoring and Monitoring
An important factor in successful capacity building is mentoring
that empowers trainees to internalize and practice newly acquired
skills under supervision. Therefore, NSCR places a high level of
importance on continuing mentoring and supervision of cancer
registries in Nigeria through telephone, e-mail, and face-to-face
mentoring visits. From 2009 to 2013, the NSCR conducted 51
mentoring andmonitoring visits to 17 cancer registries in different
parts of the country withmost of these registries visitedmore than
once. Registries are chosen for site visits based on specific criteria
outlined below:
1. New registries: newly established registries were visited to
ensure sufficient capacity to perform cancer registration exists.
During the visit, advocacy visits were paid to institutional
authorities to canvass support for cancer registration at the
site, local infrastructure including office space, staffing, exper-
tise, budgetary provisions, and local cooperation necessary for
cancer registration is evaluated.
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FIGURE 1 | Framework for effective cancer registration in developing countries.
2. HBCRs with potential to become PBCRs over a short period
of time: HBCRs that have demonstrated sufficient ability to
commence population-based cancer registration are visited.
Registries that have had a satisfactory level of case ascertain-
ment per year, high-quality data, well trained registry staff;
institutional support, formidable organizational structure, and
willingness to upgrade are considered to be potential PBCRs.
During these visits, a definite coverage population is mapped
out, potential data sources are reached, logistics for trans-
portation and data management are arranged; training on cod-
ing/classification and the use of CanReg software is provided
with the sole aim of commencing sustainable population-based
cancer registration.
3. Existing PBCRs. Registries that have attained PBCR status are
visited periodically for evaluation of registration methods and
data quality. Completeness of coverage is evaluated by visiting
established data sources and looking for possible new sources
of cancer information within the coverage area. Utilization of
medical records index cards is encouraged to ensure complete
case ascertainment. Accuracy of registration is also evaluated
using the CanReg software and the NSCR teammembers con-
duct data validation by re-abstracting and recoding a random
sample of cases for comparison with registry data.
These monitoring and mentoring visits provide an opportu-
nity to evaluate data quality and ensure best practices in cancer
registration according to international standards. Reports from
these visits are forwarded to theCancerControlUnit of the FMOH
and have brought the attention of the government to gaps in the
cancer registries system.
Advocacy
Successful implementation of cancer registration requires coop-
eration of many stakeholders in the health and non-health care
sectors whose cooperation must be assiduously cultivated. These
include private and public oncology care and pathology services
providers, medical records, vital statistics, community leaders,
patients, and government officials. To obtain effective coordina-
tion of cancer registration, all stakeholders involved must work
together.
Advocacy at the level of the hospital is particularly instrumental
in ensuring sustainability of the program. Engaging heads of
institutions, heads of medical records and cancer registry direc-
tors is crucial to generating much needed local support for the
cancer registries. Hospitals should be mandated to set up Cancer
Registry Management Committees that can oversee the function
and administration of cancer registries. These committees can
advocate to hospital management, government, and society on
behalf of cancer registries. Often identified as integral to the
success of any cancer registry is the leadership of the registry.
The director of a cancer registry is expected to play a supervisory
role and be involved in monitoring the activities of the cancer
registrars particularly as regards data abstraction and recording.
The scientific/medical qualification of registry directors while
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important is secondary to their ability to engage all stakeholders
with skill, diplomacy, and tact.
Registries in institutions where the leadership is interested in
cancer registration have often fared better than those where this is
lacking. In most institutions, the cancer registry staff is deployed
from the medical records department and may be rotated out
of the registry after they have undergone several cancer registry
trainings with new persons brought in with no knowledge of
cancer registration principles or use of the CanReg software. This
scenario can be prevented by securing the support of the head of
the medical records department.
The NSCR provides information through quarterly newslet-
ters in print and online to all institutions within the country.
These newsletters serve as an important way of disseminating
information about cancer registration activities, provide informa-
tion about upcoming trainings and encourage registries that are
making progress by profiling such registries. They also encourage
weaker registries to improve and thus create a healthy form of
in-country competition among registries.
Peer-Reviewed Publications
TheNigerian cancer registry databaseswere critically assessed and
analyzed in collaborationwith researchers at the iPRI LyonFrance.
Following the review of the registry databases and exclusion
of unsuitable submissions, findings from the Abuja and Ibadan
population-based cancer registries as well as 11 HBCRs where
published in 2 separate journal articles in 2012 (23, 28). The
PBCRs reported on the age-standardized incidence rates (ASR)
of the most common cancers in Nigeria; cancers of the breast
(54.3/100,000) and cervix in women (34.5/100,000) and cancers
of the prostate in men (19.1/100,000) (23). Information on the
number of cases by site and sex, most valid basis of diagnosis as
reported by 11 hospital-based cancer registries in Nigeria has also
been published (28).
The value of the cancer registration data generated by NSCR is
also being extended through collaborations and additional anal-
yses. A highly accessed pilot AIDS-Cancer Registry Match study
at selected institutions in Nigeria showed that the SIR (95% CI)
for the AIDS Defining Cancers was 5.7 (4.1, 7.2) and 2.0 (0.4,
3.5), for Kaposi Sarcoma (KS) and Cervical Cancer, respectively
(29). Comparing these with findings from the United States Age
Cancer Match Study by Engels et al. (30); they reported SIR over
two time periods 1990–1995 (pre-HAART) and 1996–2002 (Post-
HAART). For KS, SIR was 22,100 (pre-HAART) and 3640 (post-
HAART) and for cervical cancer SIR 4.2 (pre-HAART) and 5.7
(post-HAART). Engels and colleagues showed dramatic declines
in risk of KS but no change in risk of cervical cancer. Com-
pared to the SIR for KS and cervical cancer in Nigeria reported
by Akarolo-Anthony et al. (29), the SIR for KS is significantly
higher in the United States than in Nigeria, but this does not
hold true for cervical cancer. The effect of age heaping on cancer
rate estimation and the comparability, diagnostic validity, and
completeness in Nigerian cancer registries have also been studied
in detail (31).
The NSCR began coordinating activities of cancer registries in
Nigeria in 2009. Clearly, more still needs to be done to improve
completeness of registry coverage and data quality yet the data
produced to date serve as a valid representation of the cancer
problem in Nigeria. Efforts have been intensified to ensure con-
tinued improvement of the quality and comprehensiveness of data
collected in future through regular scheduled two monthly site
visits by a member of the NSCR team.
Cancer Incidence in 5 Continents Vol. X and
GLOBOCAN 2012
Themost recent edition of the IARCpublicationCancer Incidence
in five continents (CIV) was released in 2013 with contributions
from eight PBCRs in Africa, four of which were SSA cancer
registries of South Africa, Malawi, Zimbabwe, and Uganda. The
Ibadan cancer registry submitted data for this publication but
its data were not accepted for inclusion owing to failure to meet
the criteria for eligibility based on data quality. Other PBCRs in
Nigeria did not have data for the time period under consideration
for CIV (2003–2007). However, the Abuja, Calabar, and Ibadan
population-based cancer registries made submissions that were
included in the GLOBOCAN2012 database of the IARC launched
on the 12th of December 2013. Combined estimates from the
Ibadan, Abuja, and Calabar registries submission to GLOBOCAN
2012 on the most common cancers and their ASR are presented
in Table 3 below. These findings are similar to previous data
published in the literature (23).
The PBCRs in Ibadan, Calabar, and Abuja, Nigeria generate
data that is comparable to other international PBCR in terms of
coding methods used, definitions of incidence dates and mul-
tiple primaries. More recently, 3 other population-based cancer
registries have been created in Enugu, Sokoto and Ekiti bringing
the total number of PBCRs in Nigeria to 6 as at June 2015. An
improvement in completeness and data quality is now the primary
focus of the NSCR’s mentoring and monitoring effort in order to
generate higher quality data thatwillmeet the criteria for inclusion
in future volumes of CIV.
The NSCR’s 5-year strategic work-plan (2013–2018) includes
activities designed to improve the quality of PBCR in Nigeria;
elevate some existing HBCR to PBCR status and create new
PBCR to ensure adequate coverage of a geographical, cultural, and
TABLE 3 | Most common cancers and age standardized incidence rates in
Nigeria in 2012 (46).
Male Total cases*
(ASR per 100,000)
Female Total cases*
(ASR per 100,000)
Prostate (c.61) 11,944 (30.7) Breast (c.50) 27,304 (51.1)
Liver (c.22) 7875 (15.2) Cervix (c.53) 14,089 (29.2)
Non-Hodgkin’s
lymphoma
(C82–85, c.96)
2328 (3.7)* Liver (c.22) 4172 (8.2)
Colorectal
(c.18–21)
2164 (4.5) Colorectal
(c.18–c.21)
2008 (4.0)
Kaposi sarcoma
(c.46)
982 (1.5) Non-Hodgkin’s
lymphoma
(c.82-85, c.96)
1778 (2.8)
All sites but skin
(c.44)
37,540 (79.5) All sites but skin
(c.44)
64,622 (122.8)
*Combined estimates derived from the Ibadan, Abuja, and Calabar PBCRs.
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TABLE 4 |Major challenges of cancer registration in Nigeria.
S/No Challenges identified Key findings
1. Management and mentoring of
multiple cancer registries
Growing number of cancer registries within network requires more time, technical and financial capability to manage
Individually tailored interventions to deal with specific challenges at each registry are often required
2. Funding and institutional
commitment
Lack of registry-specific funding
Logistic and resource constraints
Rotation of cancer registry staff
Cancer registration not prioritized by host institutions
Various competing needs by infectious diseases and other areas for hospital funds
3. Inadequate education and
training
Cancer registrars with little or no computer literacy
Poor knowledge of cancer registration principles, practices, and CANREG software
Medical doctors often sent for trainings meant for hospital registry staff
4. Data collection Incompleteness of abstraction owing to lack of cooperation from data sources
Under-reporting
5. Data quality Quality indicators, such as DCO%, MV% are quite low
No mortality data for calculation of mortality incidence ratios (MI ratios)
Place of residence often inaccurate
Poor age estimation
6. Sustainability Insufficient funding opportunities for cancer registries
economically diverse country like Nigeria; extend the range of
data collected to include cancer outcomes; make Nigerian cancer
registry data freely available and accessible online for use by
researchers and policy makers behind a registration firewall and
publication of regular series on Nigerian Cancer Statistics.
Challenges of Cancer Registration in
Nigeria
While the challenges of cancer registration inNigeria are similar to
those in other African countries that have been described in pre-
vious literature (32, 33), the large population, limited health care
infrastructure, evolution of cancer registration in Nigeria, Nige-
rian laws and constitutional arrangements, which puts legislation
and responsibility for health care on the concurrent legislative
agenda of the federal and state government, among other issues
create some unique challenges (Table 4). It is inconceivable and
unnecessary for Nigeria to have cancer registries in every part of
the country, and hence, the conceptualization of a system that
envisages a limited number of population-based cancer registries
in different regions of the country so that the potential variation
across the rather large and populous country can be adequately
captured.
Management and Mentoring of Multiple Cancer
Registries
Managing the growing number of cancer registries within the
NSCR network is not trivial. Cancer registries across the country
need to be continuouslymentored, monitored, and evaluated with
feedback provided on their registration activities. The monitoring
and evaluation of this programhave often involved local and inter-
national experts who provide unbiased assessments of current sta-
tus and areas in need of improvements. Tailored interventions are
then developed for individual cancer registries as recommended
following these visits.
The NSCR bridges the gap between the government, local
institutions, stakeholders, and the individual registries. However,
cancer registration in Nigeria can only be sustained through
strong integration of NSCR within the FMOH, engagement at the
highest level of leadership in the health sector, evident contribu-
tion of cancer registries data to the FMOH for policy making and
resource allocation, and continuous advocacy. The development
of joint implementation strategies withmeasurable registry output
are also very important components.
Funding and Institutional Commitment
While there is widespread recognition of the need for cancer
registration and the data they generate, the response at indi-
vidual institutional levels has been weak. Most institutions are
unwilling or unable to support a transition from hospital to
population-based cancer registration. There are several reasons
for this including increasing use of fee for service models to run
health care in Nigeria. Institutions therefore often lack funds to
implement public health interventions like cancer registration
amidst competition for limited funds by various departments in
the hospital, inadequate staff and lack of evident “purchaser” of
cancer registration services.
The most common difficulty encountered by cancer registries
in Nigeria is inadequate resources needed to carry out their activi-
ties. Many cancer registrars and advocates have frequently supple-
mented cancer registration activities from personal resources but
this is not sustainable and often results in sporadic efforts with
long intervals between abstractions. Other models for funding
cancer registration including use of competitive grants, cooper-
ative agreements, or fee for service models need to be explored by
governments and development partners.
Education and Training
Trained personnel are a crucial resource in cancer registration
but they are in short supply. Opportunities for training and re-
training have also been limited. With the limited support for
cancer registries in institutions, support for local and interna-
tional training of staff is often not forthcoming from the hospitals
where the registries are located. The NSCR recognizing this gap,
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embarked on intensive training of registry personnel over the past
few years, nationally and internationally supported by funding
from the United States National Institutes of Health’s Fogarty
International Center and the National Cancer Institute. However,
continuous training and re-training, mentoring, monitoring, and
trouble shooting are needed for registry staff as well as registry
directors to ensure that best registry practices are upheld.
Data Collection
Lack of cooperation from data sources within a registry’s catch-
ment area adversely affects completeness of the data that the reg-
istry can collect. Our experience revealed a plethora of problems
encountered with many potential data sources. There is general
suspicion of cancer registrars, which may be related to a general
low level of trust in the society, lack of a well-established culture
of data collection and data management, and general distrust
of government and government related activities. There are also
concerns about patient confidentiality and how these would be
protected given that cancer is still a stigmatizing disease and most
patients do not share information about their disease even with
close relatives. Some data sources ask to be paid before release
of data while some refuse to cooperate for unknown reasons.
Government regulations making cancer a registrable disease (thus
empowering registrars’ access to institutional records) in contrast
to being a notifiable disease (where the onus is on institutions to
report the disease to government authorities as required by law)
would increase the authority of cancer registrars and reduce the
challenges encountered at health institutions. In many instances,
health facilities do not have organized, stored, and accessible
medical records of their own. Enforcement of existing regulations
on health records, investment inmedical records and education of
all stakeholders about their value is urgently needed.
Data Quality
Poor quality is a common problem with data from many devel-
oping countries. If data quality is low, comparability with other
regions is poor and estimates of incidence, mortality and sur-
vival are inaccurate. Information on date of birth and age are
particularly important to collect in a cancer registry for accurate
estimation of age-specific incidence (ASI) and ASR. Age data in
Nigeria are not always reliable because many individuals do not
know their age and rigorous effort is not made at medical regis-
tration to help the individual provide the best estimate through
the use of prompts although such methods also have significant
limitations. Medical records and health care workers therefore use
broad categories, such as “adult” in lieu of the age of patient. With
increasing education of the populace and use of vital statistics in
many other aspects of life, this problem should diminish over time.
Contact address information of patients is also usually incom-
plete. It is particularly important to ensure that the address pro-
vided by the patient is the “usual” residential address and not a
place of temporary abode that is used to access hospital care for
duration of treatment. It is not uncommon for patients in Nigeria
to temporarily re-locate to addresses in cities where the tertiary
institution that can provide cancer treatment is located and give
this information when their address is sought. Patients may also
be unwilling to give specific and detailed address out of a lack of
understanding of the need for such information and lack of trust
about how the information may be used. Establishing a system for
verifying addresses should be priority for all cancer registries in
Nigeria.
In Nigeria, like many other LMIC, there is poor recording of
vital statistics. Mortality data are unreliable because not all deaths
are reported, a significant proportion of deaths occur at home and
the causes are unknown. The deceased are buried in their homes
or communities without report to municipal authorities. Death
certification or autopsies are not always done so specific causes of
death are not reported (34). This lack of ancillary but necessary
vital information for cancer registries affects data quality and
limits data analysis (18). Evaluating cancer registry data quality
using the indices of completeness, validity, comparability, and
timeliness has been held back by these gaps in the vital registration
system (35–39).
Sustainability
For cancer registration efforts to be sustained in Nigeria, local
ownership is essential. While financial and technical advice pro-
vided by international partners is critical, long-term success, and
sustainability is a shared responsibility between local stakeholders
and the government. Stakeholders must accept the responsibility
to establish, sustain, and routinely monitor the system. Clear lines
of budgetary support and reporting channels must be established.
In order to establish this inNigeria, aNational CancerRegistration
Advisory Committee including representatives of the highest level
of government, members of the National Cancer Control Com-
mittee, representatives of different stakeholders in-country in the
country is being established while the NSCR continue to provide
relevant guidance, technical and scientific support.
It is essential that after receiving training and support, cancer
registries produce data of reasonably good quality that can be used
to generate information for cancer control and public policy. In
addition, such data can contribute to research on cancer and for
application for funding from relevant funding agencies.
Registry Research, Ethics, and Confidentiality
Cancer registries are notably useful sources of information on
the burden of disease in a given population by providing infor-
mation on incidence, mortality, and survival and less commonly
on prevalence and disability adjusted life years (DALYs) (40).
Other important uses of cancer registry data include descriptive
studies and analytical research into the etiology and risk factors
of specific cancers. Although as a widely acclaimed rule, most
cancer registries function under strict conditions of confidential-
ity of medical information, there are conflicting views on use of
registry data in research without previous patient consent (40).
In registries of some western countries, informed consent is now
a prerequisite for recording patient information into a registry
database (41). This legislation adversely affects the completeness
and validity of a registry’s database and several authorities in the
field have stressed that individual patient consent is not feasible
and should not be a requirement in any cancer registry (42).
In Nigeria, the National Health Research Ethics Committee has
determined that expedited approval is sufficient and has provided
this for all cancer registration work at all sites in the country
thereby ameliorating a need to seek individual approval at each
institution. This approach may help in other countries too.
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Conclusion
Central coordination of cancer registration in countries like Nige-
ria with large population and multiple cancer registries is crucial.
This enable collation, aggregation, analysis, and reporting of data,
identification of regional and local trends that can spur further
epidemiological research and generation of information that can
guide government policy and resource allocation. Such evident
benefits of cancer registration will spur local support and buy-in.
It is well-established globally that population-based cancer
registration is central to cancer registration, epidemiology, and
control programs (14, 40, 43). However, we and others have
argued that until such registries are established, there is role,
albeit limited, for hospital-based cancer registries (28, 44). Their
data can be informative and contribute to cancer control policies
and resource allocation. Governments need to consider making
cancers registrable thus empowering cancer registrars to collect
relevant information without hindrance from public and pri-
vate health institutions. Cancer registration must be entrenched
in government cancer control policies and initiative and the
government must provide guidelines on cancer registrations to
all stakeholders in the health sector. Options for funding can-
cer registration other than through competition for funds allo-
cated to support therapeutic services must be given serious
consideration.
Nigeria has recently taken major strides in improving cancer
registration. With the implementation of a central coordinating
body, the NSCR and its role in implementing and sustaining
these efforts, considering that Nigeria’s population is 17–20%
that of Africa, high-quality cancer registration from Nigeria will
significantly reduce the proportion of Africa that is not currently
covered by cancer registration. At least three population-based
cancer registries have been established or strengthened and the
quality of their data continues to improve. Several hospital-based
cancer registries are being supported and mentored to achieve
population-based registry status over the next fewmonths. Cancer
epidemiology data are being regularly produced, analyzed, and
submitted to government for advocacy, planning, policy, and
budgetary purposes. Nevertheless, more work needs to be done
to expand the scope of data collected, their quality, and their
utilization.
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